Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Asperlicin C is a member of the asperlicins class, characterized by its core 6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione skeleton, which is substituted at the 7 pro-S position by an indol-3-ylmethyl group. It functions as a cholecystokinin antagonist.
Used in Pharmaceutical Industry:
Asperlicin C is used as a cholecystokinin antagonist for its potential role in treating gastrointestinal disorders and modulating satiety and appetite. Its antagonistic activity against cholecystokinin receptors may help in managing conditions such as obesity and related metabolic disorders.

93413-06-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione,6,7-dihydro-7-(1H-indol-3-ylmethyl)-, (7S)-

    Cas No: 93413-06-0

  • No Data

  • No Data

  • No Data

  • Alfa Chemistry
  • Contact Supplier
  • 93413-06-0 Structure
  • Basic information

    1. Product Name: asperlicin C
    2. Synonyms: asperlicin C
    3. CAS NO:93413-06-0
    4. Molecular Formula: C25H18N4O2
    5. Molecular Weight: 406.443
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 93413-06-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: °Cat760mmHg
    3. Flash Point: °C
    4. Appearance: /
    5. Density: 1.43g/cm3
    6. Refractive Index: 1.766
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: asperlicin C(CAS DataBase Reference)
    10. NIST Chemistry Reference: asperlicin C(93413-06-0)
    11. EPA Substance Registry System: asperlicin C(93413-06-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 93413-06-0(Hazardous Substances Data)

93413-06-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 93413-06-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,4,1 and 3 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 93413-06:
(7*9)+(6*3)+(5*4)+(4*1)+(3*3)+(2*0)+(1*6)=120
120 % 10 = 0
So 93413-06-0 is a valid CAS Registry Number.
InChI:InChI=1/C25H18N4O2/c30-24-18-9-3-6-12-22(18)29-23(27-20-11-5-2-8-17(20)25(29)31)21(28-24)13-15-14-26-19-10-4-1-7-16(15)19/h1-12,14,21,26H,13H2,(H,28,30)/t21-/m0/s1

93413-06-0Downstream Products

93413-06-0Relevant articles and documents

An iterative, bimodular nonribosomal peptide synthetase that converts anthranilate and tryptophan into tetracyclic asperlicins

Gao, Xue,Jiang, Wei,Jimenez-Oses, Gonzalo,Choi, Moon Seok,Houk, Kendall N.,Tang, Yi,Walsh, Christopher T.

, p. 870 - 878 (2013)

The bimodular 276 kDa nonribosomal peptide synthetase AspA from Aspergillus alliaceus, heterologously expressed in Saccharomyces cerevisiae, converts tryptophan and two molecules of the aromatic β-amino acid anthranilate (Ant) into a pair of tetracyclic peptidyl alkaloids asperlicin C and D in a ratio of 10:1. The first module of AspA activates and processes two molecules of Ant iteratively to generate a tethered Ant-Ant-Trp-S-enzyme intermediate on module two. Release is postulated to involve tandem cyclizations, in which the first step is the macrocyclization of the linear tripeptidyl-S-enzyme, by the terminal condensation (CT) domain to generate the regioisomeric tetracyclic asperlicin scaffolds. Computational analysis of the transannular cyclization of the 11-membered macrocyclic intermediate shows that asperlicin C is the kinetically favored product due to the high stability of a conformation resembling the transition state for cyclization, while asperlicin D is thermodynamically more stable.

Procedure - Economical enantioselective total syntheses of asperlicins C and e

Huang, Pei-Qiang,Wang, Yu,Luo, Shi-Peng,Geng, Hui,Ruan, Yuan-Ping,Wang, Ai-E

, p. 1255 - 1258 (2015/03/04)

We report a procedure - economical method for the highly enantioselective and protecting-group free total syntheses of nonpeptidal CCK antagonists asperlicins C and E. Starting from l-tryptophan, the synthesis of asperlicin C has been achieved in three steps, which features the low-valent titanium (LVT: TiCl4-Zn combination)-mediated reductive cyclization of o-nitrobenzamide to construct the (3H)-quinazolin-4-one moiety. This is the first employment of LVT for the synthesis of asperlicin C, which allowed accessing asperlicin C in >99% enantioselectivity. Asperlicin C was converted, in one-pot, into asperlicin E and 2,3-di-epi-asperlicin E by dimethyl dioxirane (DMDO)-mediated tandem reactions. The use of DMDO as a green, cheap, and easily available oxidant to replace the photochemical method renders the synthesis of asperlicin E experimentally convenient.

Assembly of asperlicin peptidyl alkaloids from anthranilate and tryptophan: A two-enzyme pathway generates heptacyclic scaffold complexity in asperlicin E

Haynes, Stuart W.,Gao, Xue,Tang, Yi,Walsh, Christopher T.

supporting information, p. 17444 - 17447 (2013/01/15)

Members of the asperlicin family of fungal metabolites produced by Aspergillus alliaceus are known potent CCKA antagonists. Herein, we report the identification of the gene cluster responsible for directing their biosynthesis. We validate and probe the pathway by genetic manipulation, and provide the first biochemical characterization of the oxidative cyclization en route to the heptacyclic asperlicin E by reconstituting the activity of the FAD depend monooxygenase AspB. This report provides the first genetic characterization of a NRPS assembly line that efficiently activates two anthranilate building blocks and illustrates the remarkably efficient biosynthesis of the complex heptacyclic asperlicin E.

Total synthesis of asperlicin C, circumdatin F, demethylbenzomalvin A, demethoxycircumdatin H, sclerotigenin, and other fused quinazolinones

Tseng, Ming-Chung,Yang, Huei-Yun,Chu, Yen-Ho

experimental part, p. 419 - 427 (2010/02/16)

Using scandium triflate and microwaves, the direct double dehydrocyclization of anthranilate-containing tripeptides was achieved, affording the total syntheses of (i) quinazolino[3,2-a]benzodiazepinediones (1a-f), (ii) diazepino[2,1-b]quinazolinediones (2a-e), and (iii) pyrazino[2,1-b]quinazolinediones (3a-e) with good overall isolated yields (23-43%, 37-47% and 31-56%, respectively). Among the quinazolino[3,2-a] benzodiazepinediones synthesized, 1a (sclerotigenin), 1b (circumdatin F), and 1f (asperlicin C) are natural products.

Microwave-assisted concise total syntheses of quinazolinobenzodiazepine alkaloids

Liu, Ji-Feng,Kaselj, Mira,Isome, Yuko,Chapnick, Jennifer,Zhang, Bailin,Bi, Grace,Yohannes, Daniel,Yu, Libing,Baldino, Carmen M.

, p. 10488 - 10493 (2007/10/03)

One-pot total syntheses of the quinazolinobenzodiazepine alkaloids sclerotigenin (1), (±)-circumdatin F (2), and (±)-asperlicin C (3) via novel microwave-assisted domino reactions were achieved in 55%, 32%, and 20% yields, respectively, from commercially

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 93413-06-0